Ruth and Bruce Rappaport are internationally known philanthropists who have been supporting the Ruth & Bruce Rappaport Faculty of Medicine almost since its inception. In addition, they conceived, established and have generously supported the Rappaport Family Institute for Research in the Medical Sciences.

Mr. Rappaport used to quote his dear friend, Mr Shimon Peres, who said that “illnesses have no boundaries and thus medicine can be a bridge to peace.” He also used to reveal that his parents wanted him to have a career in medicine; he preferred to work in business. In order to accomplish both objectives, he worked in business and donated to medical endeavors in Israel and the USA on a grand scale.

It is indeed rare to find philanthropists who continually support a cause with such enthusiasm and high level of involvement. This is particularly true in the case of basic and clinical research, where results are not immediate or obvious. In recognition of his generosity and dedication, Mr. Rappaport was awarded Honorary Citizenship of Haifa, a Technion honorary Doctorate of Science in Technion and the Technion Medal.

In July 2023, a transformative initiative took place at the RTICC. The Rappaport Foundation and the Technion-Israel Institute of Technology united forces to establish the 10-year cancer research program of the RTICC.

The Rappaport-Technion Research Program is a cornerstone initiative, designed to propel cancer research through strategic investments in faculty recruitment, cutting-edge equipment, and state-of-the-art infrastructure. By funding fellowships that foster collaboration across disciplines, this program empowers researchers to push the boundaries of innovation in cancer diagnosis, treatment and prevention. Additionally, the program supports conferences and seminars, creating a vibrant hub for knowledge exchange. Through these comprehensive efforts, the Rappaport-Technion Research Program plays a pivotal role in advancing breakthroughs that transform cancer care worldwide.